4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Precipio, Inc. (PRPO) operates in the Diagnostics & Research industry and is headquartered in New Haven, United States with about 61 employees. Its market capitalization is roughly $44 million. In the fiscal year ended 2025-12-31, PRPO reported $24M in revenue and ($0M) in net income.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Interactive charts & full statements → Open the PRPO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $24M | $18M | $15M | $9M | — |
| Gross Profit | $11M | $8M | $6M | $2M | — |
| Operating Income (EBIT) | ($1M) | ($4M) | ($8M) | ($13M) | — |
| Net Income | ($0M) | ($4M) | ($6M) | ($12M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $7M | $7M | $7M | $6M | $5M |
| Gross Profit | $3M | $3M | $3M | $2M | $2M |
| Operating Income (EBIT) | ($1M) | $0M | ($0M) | ($1M) | ($1M) |
| Net Income | ($1M) | $0M | ($0M) | $0M | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $21M | $17M | $18M | $22M | — |
| Total Liabilities | $7M | $5M | $4M | $5M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PRPO viewer.
About TickerBase · Data methodology & sources